| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.095 | 0.1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |